Research Findings<\/h3><\/div>Fugenbio began full-scale research following a pivotal discovery.
\nAfter 10 years of dedicated study, we confirmed that Ceriporia lacerata can help improve
\ninsulin resistance and reduce elevated blood glucose levels.<\/p><\/h5><\/div><\/div><\/div>
![](\"https:\/\/fugenbio.com\/wp-content\/uploads\/2025\/04\/research_icon.png\" "\\"research_icon\\"")
<\/span><\/div><\/div><\/div><\/div><\/div>Improvement in Insulin Resistance
\n(Pre-diabetes)<\/p><\/h3><\/div>
<\/div><\/div><\/div>In a 12-week study of 72 pre-diabetic participants, daily intake of Ceriporia led to:
\nSerum insulin reduced by approx. 35.7%<\/strong>
\n<\/b>*C-peptide reduced by approx. 52.5%<\/strong><\/p><\/h6><\/div>*C-peptide is released in equal amounts to insulin during proinsulin breakdown.
\nIt remains stable in the bloodstream, making it useful for measuring insulin production and resistance.<\/p><\/p><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/fugenbio.com\/wp-content\/uploads\/2025\/04\/research_graph1-1.jpg\" "\\"research_graph1\\"")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div>Improvement in Insulin Resistance
\n(Diabetic Patients)<\/p><\/h3><\/div>
<\/div><\/div><\/div>In a subgroup of patients with insulin resistance (HOMA-IR \u2265 1.8),
\n12 weeks of Ceriporia intake led to significant improvements in both C-peptide and fasting insulin levels.<\/p><\/h6><\/div>
*Fasting plasma insulin refers to insulin measured after at least 8 hours of fasting.In insulin resistance,
\nthe body does not respond properly to insulin, leading to persistently high blood sugar levels as glucose is not absorbed into the cells efficiently.<\/p><\/p><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/fugenbio.com\/wp-content\/uploads\/2025\/04\/research_graph3-1.jpg\" "\\"research_graph3\\"")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div>Improvement in *HOMA-IR
\n(Insulin Resistance Index)<\/p><\/h3><\/div>
<\/div><\/div><\/div>In a 12-week study of 72 pre-diabetic individuals,
\ndaily intake of Ceriporia resulted in a 34% decrease in total HOMA-IR levels.
\nAmong participants with higher insulin resistance (HOMA-IR \u2265 1.66), the decrease reached approximately 61%.<\/p><\/h6><\/div>
*HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is a marker calculated using fasting insulin and glucose levels.
\nHigher values indicate greater insulin resistance.<\/p><\/p><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/fugenbio.com\/wp-content\/uploads\/2025\/04\/research_graph4-1.jpg\" "\\"research_graph4\\"")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div>Liver Enzyme Improvement<\/h3><\/div><\/div><\/div><\/div>In diabetic patients taking medication, 12 weeks of Ceriporia intake led to a significant improvement in *ALT levels.<\/h6><\/div>*ALT (Aspartate Aminotransferase) is a liver enzyme released into the bloodstream when liver cells are damaged.
\nIt is commonly elevated in cases of fatty liver, diabetes, or metabolic disorders.<\/p><\/p><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>![](\"https:\/\/fugenbio.com\/wp-content\/uploads\/2025\/04\/research_graph5-1.jpg\" "\\"research_graph5\\"")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-3727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/pages\/3727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/comments?post=3727"}],"version-history":[{"count":7,"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions"}],"predecessor-version":[{"id":3735,"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/pages\/3727\/revisions\/3735"}],"wp:attachment":[{"href":"https:\/\/fugenbio.com\/en\/wp-json\/wp\/v2\/media?parent=3727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Fugenbio began full-scale research following a pivotal discovery.
\nAfter 10 years of dedicated study, we confirmed that Ceriporia lacerata can help improve
\ninsulin resistance and reduce elevated blood glucose levels.<\/p><\/h5><\/div><\/div><\/div>
<\/span><\/div><\/div><\/div><\/div><\/div>Improvement in Insulin Resistance
\n(Pre-diabetes)<\/p><\/h3><\/div>
In a 12-week study of 72 pre-diabetic participants, daily intake of Ceriporia led to: *C-peptide is released in equal amounts to insulin during proinsulin breakdown. Improvement in Insulin Resistance In a subgroup of patients with insulin resistance (HOMA-IR \u2265 1.8), *Fasting plasma insulin refers to insulin measured after at least 8 hours of fasting.In insulin resistance, Improvement in *HOMA-IR In a 12-week study of 72 pre-diabetic individuals, *HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is a marker calculated using fasting insulin and glucose levels. *ALT (Aspartate Aminotransferase) is a liver enzyme released into the bloodstream when liver cells are damaged.
\nSerum insulin reduced by approx. 35.7%<\/strong>
\n<\/b>*C-peptide reduced by approx. 52.5%<\/strong><\/p><\/h6><\/div>
\nIt remains stable in the bloodstream, making it useful for measuring insulin production and resistance.<\/p><\/p><\/div><\/div><\/div><\/span><\/div>
\n(Diabetic Patients)<\/p><\/h3><\/div>
\n12 weeks of Ceriporia intake led to significant improvements in both C-peptide and fasting insulin levels.<\/p><\/h6><\/div>
\nthe body does not respond properly to insulin, leading to persistently high blood sugar levels as glucose is not absorbed into the cells efficiently.<\/p><\/p><\/div><\/div><\/div><\/span><\/div>
\n(Insulin Resistance Index)<\/p><\/h3><\/div>
\ndaily intake of Ceriporia resulted in a 34% decrease in total HOMA-IR levels.
\nAmong participants with higher insulin resistance (HOMA-IR \u2265 1.66), the decrease reached approximately 61%.<\/p><\/h6><\/div>
\nHigher values indicate greater insulin resistance.<\/p><\/p><\/div><\/div><\/div><\/span><\/div>Liver Enzyme Improvement<\/h3><\/div>
In diabetic patients taking medication, 12 weeks of Ceriporia intake led to a significant improvement in *ALT levels.<\/h6><\/div>
\nIt is commonly elevated in cases of fatty liver, diabetes, or metabolic disorders.<\/p><\/p><\/div><\/div><\/div><\/span><\/div>